| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Kidney Research Centre, Ottawa Health Research Institute, University of Ottawa, Ottawa, Ontario, Canada. * To whom correspondence should be addressed. E-mail: rtouyz{at}uottawa.ca.
Related Article:
Regulation of Endothelial Nitric Oxide Synthase by Thrombin
Rhian M. Touyz*
Hypertension 2007 49: 577-583.
This article has been cited by other articles:
![]() |
V. L. Watts and E. D. Motley Role of Protease-Activated Receptor-1 in Endothelial Nitric Oxide Synthase-Thr495 Phosphorylation Experimental Biology and Medicine, February 1, 2009; 234(2): 132 - 139. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Strande, A. Hsu, J. Su, X. Fu, G. J. Gross, and J. E. Baker Inhibiting Protease-Activated Receptor 4 Limits Myocardial Ischemia/Reperfusion Injury in Rat Hearts by Unmasking Adenosine Signaling J. Pharmacol. Exp. Ther., March 1, 2008; 324(3): 1045 - 1054. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |